H and 13 C NMR spectra were obtained at 300 MHz and 125 MHz, respectively, with a Bruker DPX-300 NMR spectrometer. Chemical shifts (ppm) and coupling constants (J) are reported in parts per million and Hertz, respectively. The abbreviations for splitting patterns are s, singlet; br s, broad singlet; d, doublet, t, triplet; q, quartet; m, broad multiplet, and combinations therein (i.e. dd, doublet of doublets). Flash chromatography was performed using EM Science flash silica gel, 230-400 mesh. Mass spectral data were obtained at the University of Massachusetts Mass Spectrometry Facility which is supported, in part, by the National Science Foundation grant CHE-9974648. X-ray data were collected using a Nonius kappa-CCD diffractometer with MoKá (ë=0.71072 Å) as the incident radiation. Diffraction data were collected at ambient temperature unless otherwise stated. The raw data were integrated, refined, scaled, and corrected for Lorentz polarization and absorption effects, if necessary, using the programs DENZO and SCALEPAK, supplied by Nonius. Structure solutions and refinements were done using a suite of programs such as SIR97, SIR92, LSQ, SHELXS and SHELXL that are contained within the Nonius MAXUS module. All structures were checked for any missing symmetry using MISSYM of PLATON. Single crystals of 5, 8, and 9 were grown by slow evaporation of the chloroform or chloroform -ethanol solution at room temperature.
MIC 90 was determined by measuring cell growth at OD 600 after 6 hours. MIC 90 is a greater than 90 percent reduction in cell count compared to the control sample in the absence of antimicrobial agent. Each plate contains duplicate runs and a minimum of three plates, or six data sets, were collected. The control, MSI-78, was tested against the same E. coli D31 strain.
Hemolysis Assay. Hemolysis experiments were performed by incubating a 0.35% suspension of fresh human erythrocytes (RBCs) in 10 mM Tris buffer containing 150 mM NaCl at pH 7.0 with varying amounts of polymer. Hemolysis samples were prepared in 96-well plates by combining 80 µL of the washed RBC suspension with 20 µL total of buffer containing the oligomer in serial two-fold dilution. After incubation for 30 minutes at 37°C, the suspensions were centrifuged at 3000 rpm for 5 minutes. An aliquot of the supernatant was diluted with buffer and OD 414 of the solution (due to released hemoglobin) was measured. Complete hemolysis was measured by adding 1% Triton X-100 to the RBC's and measuring OD 414 . The HC 50 , or hemolytic dose required to lyse 50% of the RBC's, is reported. In all cases, this value is taken directly from the fitted curve of the data.
Biological Activity Control: MSI-78, which is a Magainin derivative, was measured against the same E. coli strain as a control.
Structure E. coli B. subtilis HC 50 HC 50 /MIC E. coli
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MSI-78
12.5 -120 9.6 Selectivity Synthesis:
Synthesis of Pyrimidine Trimer (5) and Pentamer (6): 336 mg (2 mmol) of 4,6-pyrimidine dicarboxylic acid was dissolved in 20 mL dry DMSO solution. 640 mg (4 mmol) of CDI (Carbonyl Diimidazole) was added portion by portion. The reaction was stirred for 5 hours under the protection of nitrogen at room temperature. 2.50 g (7.4 mmol) of 2,6-Diamino-4-t-butyl-1-(2-t-butoxycarbonylaminoethyl) sulfanylbenzene was added. The resulting mixture was heated at 110 °C for 24 hours. After the reaction mixture was cooled to room temperature, 200 mL ethyl acetate was added. The mixture was washed successively with saturated potassium carbonate solution and sodium chloride solution. The organic layer was evaporated to dryness and purified by flash chromatography. The eluent is 200:10:1 methylene chloride/ethyl acetate/methanol and afforded 1.13 g of pyrimidine trimer 5 and 40 mg of pyrimidine pentamer 6, obtained in 70% and 3% yield respectively. 90, 159.23, 157.33, 155.71, 154.94, 149.19, 139.75, 116.31, 108.75, 107.53, 102.47, 79.54, 39.86, 35.02, 34.86, 31.03, m/z: 810.40 (calcd) Aniline 4,6-Pyrimidine Diamide (8): 336 mg (2 mmol) of 4,6-pyrimidine dicarboxylic acid was dissolved in 20 mL dry DMSO solution. 640 mg of (4 mmol) CDI (Carbonyl Diimidazole) was added portion by portion. The reaction was stirred for 5 hours under the protection of nitrogen at room temperature. 500 mg (5.4 mmol) of aniline was added. The resulting mixture was heated at 110 °C for 24 hours. After the reaction mixture was cool to room temperature, 100 ml ethyl acetate was added. The mixture was washed with saturated potassium carbonate solution and sodium chloride solution. The organic layer was dried with MgSO 4 and evaporated to dryness. The crude product was purified by flash chromatography. The eluent is 100: 5 methylene chloride/ethyl acetate to afford 440 mg of 8 in 70% yield. 84, 159.32, 157.30, 137.81, 128.74, 124.62, 120.74, 116.05 . (9) Aniline 1.3-Benzene Diamide (9): 680 mg (4 mmol) of isophthalic acid was dissolved in 20 mL dry DMSO solution. 1,280 mg (4 mmol) of CDI (Carbonyl Diimidazole) was added portion by portion to the above solution. The reaction was stirred for 5 hours under the protection of nitrogen at room temperature. 1,000 mg (10.8 mmol) of aniline was added. The resulting mixture was heated at 120 °C for 24 hours. After the reaction mixture was cooled to room temperature, it was poured into 200 ml ice-water, the solid was filtered and washed with ethyl acetate. It was dried under vacuum. 1.0 g of 9 was obtained in 80% yield. 1 H NMR (300 MHz, DMSO-d 6 ): δ = 10.44 (s, 2H), 8.54 (s, 1H), 8.14 (d, 2H, J = 7.7 Hz), 7.80 (d, 4H, J = 7.7 Hz), 7.68 (t, 1H, J = 7.7 Hz), 7.39 ( t, 4H, J = 7.7Hz), 7.12 (t, 2H, J = 7.4Hz).
13
C NMR (125 MHz, DMSO-d 6 ): δ = 165. 16, 139.14, 135.28, 130.73, 128.72, 127.10, 123.89, 120.47 .
General procedure for deprotection of trimer 5 and pentamer 6: A 10 mL round bottom flask was charged with a magnetic stir bar. 25 mg of Boc protected oligomer (5 or 6) was added to the flask. The flask was then cooled to 0 ο C and 6 mL of 4M HCl in dioxane was added to the trimer or the pentamer. The solution was allowed to warm up to room temperature and stir overnight. The solvent was evaporated under reduced pressure and the solid was titrated with ether three times and dried under vacuum to yield a yellow solid (10 or 12). Model compounds 8 and 9 do not provide diagnostic NOE's. There is no NOE for 8 which is diagnostic for the extended structure; however, a similar amide NH-aromatic proton ortho to the carbonyls (2 position) is not observed. For 9, no signal was observed between the amide NH's and central ring suggesting rotation is fast or conformation is lock away from possible interactions. It was important initially to establish the overall conformation of the compounds. Some details are presented here. For 5' and 7' there are two thioether sidechains which stick out of the plane of the backbone, and thus it was necessary to check whether the sidechains should be on the same side (C s symmetry) or opposite sides (C 2 ) of the backbone plane. For 5', a C 2 symmetry structure is shown in Figure 6 ; however, a nearly isoenergic C s symmetric structure was also found and is shown in Figure S4 . The C 2 structure was more stable by only 0.1 kcal/mol. 7' was also found to have both C 2 and C s symmetry conformations. As with 5', the C 2 structure is more stable by only 0.1 kcal/mol. Neither the C 2 nor C s symmetric conformation of 7' produces a nonplanar backbone. Similarly among the various nonplanar structures of 9, there are two syn/anti conformations, shown in Figure S5 , which are quasi-C s and quasi-C 2 . The quasi-C s structure of 9 shown in Figure 6 is more stable but only slightly (by 0.2 kcal/mol).
5', C 2
5', C s 7', C 2 7', C s Figure S5 . B3LYP/6-311G(d,p) optimized geometries of C 2 and C s conformations of structures having two thioether sidechains, 5' and 7'. The C 2 structures are more stable, by 0.1 kcal/mol for 5' and by 0.2 kcal/mol for 7' (including zero-point energy).
9, quasi-C 2
9, quasi-C s Figure S6 . B3LYP/6-311G(d,p) optimized geometries of quasi C 2 and C s conformations of syn/anti 9. The C s one is more stable by 0.2 kcal/mol (including zero-point energy). 
